A detailed history of Bank Of America Corp transactions in Bridge Bio Pharma, Inc. stock. As of the latest transaction made, Bank Of America Corp holds 478,473 shares of BBIO stock, worth $13.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
478,473
Previous 643,260 25.62%
Holding current value
$13.7 Million
Previous $16.3 Million 25.24%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$23.91 - $31.3 $3.94 Million - $5.16 Million
-164,787 Reduced 25.62%
478,473 $12.2 Million
Q2 2024

Aug 14, 2024

SELL
$23.0 - $31.04 $4.01 Million - $5.42 Million
-174,482 Reduced 21.34%
643,260 $16.3 Million
Q1 2024

May 15, 2024

BUY
$27.35 - $40.45 $10.8 Million - $15.9 Million
393,504 Added 92.76%
817,742 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$24.02 - $43.89 $7.22 Million - $13.2 Million
-300,470 Reduced 41.46%
424,238 $17.1 Million
Q2 2023

Aug 14, 2023

SELL
$13.29 - $18.01 $8.51 Million - $11.5 Million
-640,349 Reduced 46.91%
724,708 $12.5 Million
Q1 2023

May 12, 2023

BUY
$7.17 - $18.55 $3.72 Million - $9.63 Million
519,245 Added 61.39%
1,365,057 $22.6 Million
Q4 2022

Feb 10, 2023

BUY
$6.74 - $11.52 $2.09 Million - $3.58 Million
310,483 Added 58.0%
845,812 $6.45 Million
Q3 2022

Nov 14, 2022

SELL
$7.94 - $12.36 $195,339 - $304,080
-24,602 Reduced 4.39%
535,329 $5.32 Million
Q2 2022

Aug 12, 2022

SELL
$5.21 - $12.14 $3 Million - $6.99 Million
-576,140 Reduced 50.71%
559,931 $5.08 Million
Q1 2022

May 16, 2022

BUY
$7.34 - $17.16 $3.76 Million - $8.79 Million
512,411 Added 82.16%
1,136,071 $11.5 Million
Q4 2021

Feb 08, 2022

BUY
$11.38 - $53.41 $1.54 Million - $7.24 Million
135,616 Added 27.79%
623,660 $10.4 Million
Q3 2021

Nov 15, 2021

SELL
$46.87 - $64.24 $2.55 Million - $3.49 Million
-54,393 Reduced 10.03%
488,044 $22.9 Million
Q2 2021

Sep 13, 2021

BUY
$46.47 - $63.93 $25.2 Million - $34.7 Million
542,437 New
542,437 $33.1 Million

Others Institutions Holding BBIO

About BridgeBio Pharma, Inc.


  • Ticker BBIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 148,246,000
  • Market Cap $4.23B
  • Description
  • BridgeBio Pharma, Inc. engages in the discovery, development, and delivery of various medicines for genetic diseases. The company has a pipeline of 30 development programs that include product candidates ranging from early discovery to late-stage development. Its products in development programs include AG10 and BBP-265, a small molecule stabili...
More about BBIO
Track This Portfolio

Track Bank Of America Corp Portfolio

Follow Bank Of America Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of America Corp with notifications on news.